MICHAEL ADEDURO: Open Payments
NPI 1386352789 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $480 · 2025 $300
Food & beverage: $295Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $156 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $7 |
Products named: INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, REXULTI, AUSTEDO XR, COBENFY.
Industry payments across CA — which companies pay providers there.
